CNS pipeline · person
Ian Mortimer, MBA, CPA, CMA
President and CEO of Xenon Pharmaceuticals since June 2021, having previously served as President and Chief Financial Officer; he is also a member of the Board. Before Xenon he was EVP and CFO of Tekmira Pharmaceuticals (now Arbutus Biopharma), and he holds an MBA from Queen's University and a B.Sc. in Microbiology from the University of British Columbia.
- 1 company
Courtesy Xenon Pharmaceuticals
Current roles
- Xenon Pharmaceuticals Inc.President and Chief Executive Officer · Executive
- Xenon Pharmaceuticals Inc.Director · Board
Appears with
People sharing a company with Ian.
- Andrea DiFabio · Xenon Pharmaceuticals Inc.
- Christopher Kenney · Xenon Pharmaceuticals Inc.
- Darren Cline · Xenon Pharmaceuticals Inc.
- Dawn Svoronos · Xenon Pharmaceuticals Inc.
- Elizabeth Garofalo · Xenon Pharmaceuticals Inc.
- Gary Patou · Xenon Pharmaceuticals Inc.
- Gillian Cannon · Xenon Pharmaceuticals Inc.
- James Empfield · Xenon Pharmaceuticals Inc.
- Justin Gover · Xenon Pharmaceuticals Inc.
- Matthew D. Ronsheim · Xenon Pharmaceuticals Inc.
- Michael Hayden · Xenon Pharmaceuticals Inc.
- Patrick Machado · Xenon Pharmaceuticals Inc.
- Robin Sherrington · Xenon Pharmaceuticals Inc.
- Shelley McCloskey · Xenon Pharmaceuticals Inc.
- Steven Gannon · Xenon Pharmaceuticals Inc.
- Tucker Kelly · Xenon Pharmaceuticals Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.